fbpx
May 10, 2023

How the End of the COVID Public Health Emergency May Affect You How the End of the COVID Public Health Emergency May Affect You

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The federal public health emergency for COVID-19, in place in the United […]
May 9, 2023

Clinical Trials: Top Priority for Long COVID Clinical Trials: Top Priority for Long COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Centers for Disease Control and Prevention (CDC) and the US Census […]
May 9, 2023

ChatGPT Delivers Credible Answers to Colonoscopy Queries ChatGPT Delivers Credible Answers to Colonoscopy Queries

ChatGPT, an artificial intelligence (AI) chatbot, can provide easily understandable, scientifically adequate, and generally satisfactory answers to common patient questions about colonoscopy, new research suggests. “This […]
May 9, 2023

Youth Depression Jumped During the Pandemic, Study Finds Youth Depression Jumped During the Pandemic, Study Finds

Children and adolescents experienced an increase in depression and anxiety during the COVID-19 pandemic compared with before the worldwide healthcare crisis, with females from higher income […]
May 9, 2023

Axial SpA vs Axial PsA: Different Entities? Axial SpA vs Axial PsA: Different Entities?

Are there clinically significant differences between axial spondyloarthritis with psoriasis and psoriatic arthritis with axial symptoms? Does it matter? It all depends on whom you ask, […]
May 9, 2023

Drug Development Inquiries for Drugs to Address the COVID-19 Public Health Emergency

On this page CDER is committed to supporting the development of novel drugs, and the potential repurposing of existing therapies, to address the Coronavirus Disease 2019 […]
May 9, 2023

Stakeholder Engagement | COVID-19

FDA is committed to continued engagement with patients, pharmacists, physicians, and healthcare professional organizations, as well as other stakeholders, to address the critical public health crisis […]
May 9, 2023

Bioequivalence Studies for Submission in ANDAs during the COVID-19 Pandemic

Bioequivalence Studies for Submission in ANDAs during the COVID-19 Pandemic FDA recognizes that the COVID-19 pandemic may impact the conduct of bioequivalence studies intended for submission […]
May 9, 2023

Registration and Listing Assistance for Non-Traditional Manufacturers of Hand Sanitizer and Related COVID-19 Drugs

FDA requires companies that manufacture drugs to register their manufacturing facilities and list their drug products with FDA. This includes companies that are manufacturing drugs to address […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0